Z3 Capital Partners’s Profound Medical PROF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.54M Sell
783,141
-37,800
-5% -$257K 0.94% 30
2026
Q2
$5.46M Buy
820,941
+2,950
+0.4% +$19.8K 1.15% 26
2026
Q1
$5.3M Sell
817,991
-950
-0.1% -$6.56K 1.34% 21
2025
Q4
$6.45M Buy
+818,941
New +$5.26M 1.55% 16

Other funds holding PROF

Z3 Capital Partners's PROF Position: Q3 2026 in Review

Z3 Capital Partners reduced its Profound Medical (PROF) stake by 4.6% in Q3 2026, selling an estimated $257K and leaving 783,141 shares worth $4.54M. The position accounts for 0.94% of the portfolio, ranked #30.

Z3 Capital Partners first reported a position in PROF in Q4 2025 and has held it in 4 quarters since. The position peaked at $6.45M in Q4 2025. 43 funds tracked by Wall St. Rank hold PROF as of Q3 2026.

  • Z3 Capital Partners held 783,141 shares of Profound Medical worth $4.54M as of Q3 2026.
  • Z3 Capital Partners sold 37,800 Profound Medical shares in Q3 2026, an estimated $257K.
  • Profound Medical made up 0.94% of Z3 Capital Partners's portfolio in Q3 2026, its #30 holding.
  • Z3 Capital Partners first reported a position in Profound Medical in Q4 2025 and has held it in 4 quarters since.
  • Z3 Capital Partners's Profound Medical position peaked at $6.45M in Q4 2025.
  • 43 funds tracked by Wall St. Rank held Profound Medical as of Q3 2026.

Based on Z3 Capital Partners's 13F filing for Q3 2026, filed 10 Nov 2026.